Significance of hepatocyte growth factor (HGF) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Significance of angiopoietin-2 as a serum marker for hepatocellular carcinoma

Diagnostic and prognostic value of PIVK-II, TGF-beta-1, VEGF and AFP in the diagnosis of benign and malignant liver diseases

Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma

Osteopontin as a potential biomarker for hepatocellular carcinoma

Biochemical markers of liver fibrosis in HCV patients

Glypican 3 as a novel marker for hepatocellular carcinoma